Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome

<div>MSC-based effects observed in a patient with critically severe COVID-19 infection. MSCs significantly improved oxygenation, suppressed detrimental immune response in the lungs, alleviated systemic inflammation, and attenuated SARS-CoV-2 induced ARDS in a patient with critically severe COVID-19 infection.</div>

Analytical Cellular Pathology

fig3

Figure 3

Figure 3: Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome 

Figure 3 | Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome 